HALO logo
halo search icon
DBV
DBV Technologies SA

DBV · DBV Technologies SA

1.69

EUR
-0.087 (-4.899%)
08/10/2026 12:00:00 AM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Euro558.35M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 08/10/2026 12:00:00 AM

Price Chart

Description

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.

  • All-Companies
  • All-Consensus
  • HALO 100
  • HALO 200
  • HALO All
  • HALO Consensus Value
  • HALO Growth
  • Near Support

Key Fundamentals

EPS 3 yr Growth

-21.20%

EBITDA Margin

N/A

Operating Cashflow

-€107m

Free Cash Flow Return

-118.80%

ROIC

-144.00%

Interest Coverage

N/A

Quick Ratio

3.70

Performance

52 weeks range

Low 1.72 - 4.5

Trade Value (12mth)

US$1,056,231.00

1 week

-14.37%

1 month

-24.68%

YTD

-45.6%

1 year

-33.48%

All time high

86.64

Additional Data

Shares Outstanding (Fully Diluted)

434m

HALO Sector

Healthcare

Next Company Report Date

11-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

EUR

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Neutral

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
MPM BioImpact LLCPrivate Company
BPIFrance Investissement SASSubsidiary
Invus Financial Advisors LLCPrivate Company
Venrock AssociatesPrivate Company
Pharis MohideenIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of DBV Technologies SA (DBV:PAR)?
Halo FAQ
The current share price of DBV Technologies SA (DBV:PAR) is EUR€1.69.
2
What is the 52-week high share price for DBV Technologies SA (DBV:PAR)?
Halo FAQ
The 52-week high share price for DBV Technologies SA (DBV:PAR) is EUR€4.50.
3
What is the 52-week low share price for DBV Technologies SA (DBV:PAR)?
Halo FAQ
The 52-week low share price for DBV Technologies SA (DBV:PAR) is EUR€1.72.
4
What is the dividend yield for DBV Technologies SA (DBV:PAR)?
Halo FAQ
DBV Technologies SA (DBV:PAR) does not pay a dividend.
5
What was DBV Technologies SA (DBV:PAR) last dividend payment?
Halo FAQ
DBV Technologies SA (DBV:PAR) does not pay a dividend.
6
What is the franking level for DBV Technologies SA (DBV:PAR)?
Halo FAQ
DBV Technologies SA (DBV:PAR) has a franking level of 0.00%.
7
In which sector is DBV Technologies SA (DBV:PAR) classified?
Halo FAQ
DBV Technologies SA (DBV:PAR) is classified in the Healthcare.